Solano Clinical Research Report issue

For profit Phase 1 Phase 3
Founded: Petaluma CA United States (2009)
Status: Acquired by Dow Pharmaceutical Sciences (2001) → now Bausch Health Companies (2008)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Solano Clinical Research, 635 Anderson Road #17, Davis CA 95616, USA

Active Ingredients

Drugs in Phase 3 Trials (1)

tea (1 trial)

Drugs in Phase 1 Trials (1)

menadiol (synkavite) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Condylomata Acuminata (Phase 3)

Exanthema (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2